Sangamo Therapeutics Files 8-K Report
Ticker: SGMO · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1001233
| Field | Detail |
|---|---|
| Company | Sangamo Therapeutics, Inc (SGMO) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: SGMO
TL;DR
Sangamo Therapeutics filed an 8-K on 6/24/25. No specific details yet, but it's an official SEC disclosure.
AI Summary
On June 24, 2025, Sangamo Therapeutics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and does not detail specific transactions or financial figures within the provided text. The report confirms Sangamo's identity, incorporation in Delaware, and principal executive offices in Richmond, California.
Why It Matters
This filing indicates a routine update or disclosure from Sangamo Therapeutics to the SEC, which may contain important information for investors regarding the company's operations or significant events.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing header and does not contain information that inherently poses a high risk.
Key Players & Entities
- SANGAMO THERAPEUTICS, INC. (company) — Registrant
- June 24, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 501 Canal Blvd., Richmond, California 94804 (address) — Principal Executive Offices
- 000-30171 (filing_id) — SEC File Number
FAQ
What is the primary purpose of this 8-K filing?
The filing is a Current Report on Form 8-K, indicating "Other Events" as the item information, filed on June 24, 2025.
What is the exact name of the reporting company?
The exact name of the registrant is SANGAMO THERAPEUTICS, INC.
In which state is Sangamo Therapeutics, Inc. incorporated?
Sangamo Therapeutics, Inc. is incorporated in Delaware.
What are the principal executive offices of Sangamo Therapeutics, Inc.?
The principal executive offices are located at 501 Canal Blvd., Richmond, California 94804.
What is the SEC file number for Sangamo Therapeutics, Inc.?
The SEC file number for Sangamo Therapeutics, Inc. is 000-30171.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding SANGAMO THERAPEUTICS, INC (SGMO).